Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease.
D018951:Antigens, CD20 / Q000378:metabolism*; D003165:Complement System Proteins / Q000378:metabolism; D016650:Fluorescein-5-isothiocyanate / Q000378:metabolism; D041722:Genes, Transgenic, Suicide; D015316:Genetic Therapy; D006086:Graft vs Host Disease / Q000628:therapy*; D006801:Humans; D010641:Phenotype; D013601:T-Lymphocytes / Q000378:metabolism*; D014161:Transduction, Genetic
D018951:Antigens, CD20; D003165:Complement System Proteins; D016650:Fluorescein-5-isothiocyanate